12 results
COVID-19 POCUS

96 yrs old, discharged 3 wks ago for CAP, treated with amox/clav then cefixime. Returns
Returns for dyspnea ... CXR with consolidation ... #POCUS #Clinical ... #Lung #Ultrasound ... #SARSCoV2 #Coronavirus
COVID-19 on Lung POCUS

Day 4 after COVID diagnosis. More cough & tiredness (very badly), still no
COVID-19 on Lung ... badly), still no dyspnea ... #COVID19 #clinical ... #lung #ultrasound ... #pulmonary #BLines
COVID-19 Intubation Checklist

Personal protective equipment (PPE)
 • Standard PPE
   • N95 or PAPR.
COVID-19 Intubation ... Checklist Personal ... Internet Book of Critical ... #Intubation #Checklist ... #SARSCoV2 #Management
COVID-19 - Subpleural Consolidations on Lung POCUS

Doing daily POCUS LUS for ICU COVID-19 patients in Singapore
on Lung POCUS ... Helps with management ... conserve valuable PPEs ... #COVID19 #clinical ... #pulmonary #POCUS
COVID-19 Lung POCUS 

This is a POCUS of a patient with COVID-19.
No prior pulmonary disease; had
COVID-19 Lung POCUS ... No prior pulmonary ... subpleural nodular consolidation ... POCUS #Subpleural #Clinical ... #SARSCoV2 #Coronavirus
Checklist for removing PPE, using a tear-away gown here (this type of gown is preferred)
Inside the
Checklist for removing ... PPE, using a tear-away ... Internet Book of Critical ... #Management #COVID19 ... #SARSCoV2 #PersonalProtectiveEquipment
Cryptogenic Organizing Pneumonia (COP)

Cryptogenic Organizing Pneumonia Overview:
 • Idiopathic form of organizing pneumonia
 • formerly BOOP
Organizing Pneumonia - Clinical ... History: cough, dyspnea ... • HRCT: patchy consolidation ... Pneumonia #COP #BOOP #pulmonary ... ILD #diagnosis #management
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) and Pulmonary Thromboendarterectomy
Chronic Thromboembolic Pulmonary Hypertension
Definition: mean pulmonary-artery pressure > 25mmHg
Plexiform-lesion formation Clinical ... Exercise intolerance, dyspnea ... 6 months after PE ... Ventilation-perfusion lung ... Thromboendarterectomy #diagnosis #management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
affecting the lungs ... characteristic features Clinical ... hemoptysis • Dyspnea ... assay (IGRA) • PPD ... TB #Diagnosis #Management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
affecting the lungs ... characteristic features Clinical ... hemoptysis • Dyspnea ... assay (IGRA) • PPD ... TB #Diagnosis #Management